Filing Details
- Accession Number:
- 0001370820-10-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-27 12:00:00
- Reporting Period:
- 2010-01-25
- Filing Date:
- 2010-01-27
- Accepted Time:
- 2010-01-27 16:03:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131907 | Micromet Inc. | MITI | Biological Products, (No Disgnostic Substances) (2836) | 522243564 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1370820 | Matthias Alder | C/O Micromet, Inc. 6707 Democracy Blvd., Ste. 505 Bethesda MD 28017 | Svp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-01-25 | 10,000 | $1.75 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-01-25 | 10,000 | $8.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2010-01-25 | 10,000 | $0.00 | 10,000 | $1.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,469 | 2009-03-18 | 2018-03-31 | No | 4 | M | Direct |
Footnotes
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $8.15 to $8.315 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
